Health
Provisions for the Pharmaceutical Services Committee of Inquiry are under the National Health Act 1953. The Act allows a Committee to be established at either a state or federal level. The current Federal level committee was most recently established in 2015 to investigate matters of non-compliance with a pharmacist’s approval to supply Pharmaceutical Benefits Scheme (PBS) medicines, including the conditions of approval. In particular, where PBS medicines are being supplied at premises for which the pharmacist is not approved. The Act specifies the membership of the Committee consists of four pharmacists appointed by the Minister for Health as well as the Secretary of the Department of Health (or their delegate who must be a Departmental officer who is a medical practitioner or pharmacist).

Further information

  • Type of Body

    E. Statutory Office Holder Offices and Committees

  • Established By / Under

    Act / Regulation

  • Established By/Under More info

    National Health Act 1953

  • Paid Members?

    Yes

  • Max No. of Board/Committee Members

    5

  • Annual Report Prepared and tabled?

    No

  • Classification

    B. Secondary

  • Function Categorization

    Regulatory / Review / Inquiry / Commission

  • Creation Date

    20 April 2015

Current board appointments

Position Appointee Start Date End Date
Member Ms Ms. Juliana Sestan 20 April 2021 Determined by the appointer
Member Ms. Renae Beardmore 20 April 2021 Determined by the appointer
Member Ms. Helen Dowling 20 April 2021 Determined by the appointer
Member Mr. Peter Downing 1 March 2020 Determined by the appointer
Last updated: